retatrutide fair oaks Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Fair Oaks Rehabilitation & Health

Pregnant or planning to become pregnant Conclusion GLPs are a game-changer in the treatment of type 2 diabetes and obesity

Drinking alcohol with this medicine increases the risk of a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood)

If you are someone with modestly increased weight but are otherwise healthy, I think its important that you consider what you might change about your diet and physical activity to promote good health, as opposed to looking for a short-term tool to make the number on the scale go down quickly

The Semaglutide injection works by slowing down how quickly food leaves your stomach and allows you to feel full for a longer period of time

For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog

Why the Third Hormone Matters: Metabolic Impact The inclusion of glucagon agonism is what makes the retatrutide vs tirzepatide comparison so compelling from a functional and anti-aging perspective